Review suggests vitamin K as potential 'missing link' in COVID-19

By Nikki Hancocks contact

- Last updated on GMT

getty | andriano_cz
getty | andriano_cz

Related tags: Vitamin k, COVID-19

A new review presents vitamin K metabolism as the potential missing link between lung damage and thromboembolism, two of the most serious outcomes observed in COVID-19 patients.

A key concern with COVID-19 patients is the development of respiratory failure due to pneumonia but another frequent manifestation contributing to poor outcomes, is thrombosis (the formation of a blood clots).

The mechanisms leading from pulmonary infection to systemic coagulopathy in Covid-19 have not yet been entirely elucidated. It has previously been shown​ that severe vitamin K deficiency in critically ill patients can be misdiagnosed as disseminated intravascular coagulation (a condition in which small blood clots develop throughout the bloodstream, blocking small blood vessels).

Vitamin K plays a crucial role in activation of both pro- and anticlotting factors in the liver, and the activation of synthesised protein S which seems to be important in thrombosis prevention. 

A new research review, funded by Kappa Bioscience AS, a manufacturer of vitamin K2 (MK-7), notes that insufficient vitamin K-dependent matrix Gla protein activation leaves elastic fibres unprotected against COVID-19.

The authors suggest that vitamin K-dependent endothelial protein S activation is also compromised in COVID-19, which would lead to a tendency for clotting.

They propose that insufficient activation of protein S in blood vessel walls and matrix Gla protein (MGP) in the lungs may lead to an increased risk for thrombosis, and lung damage, respectively. 

“Considering that vitamin K is important for regulating lung health and blood clotting, vitamin K deficiency during COVID-19 may make both those problems worse,”​ explain Dr. Rob Janssen and Jona Walk, researchers at the Canisius Wilhelmina Hospital (Nijmegen, The Netherlands), and lead authors of the study.

The report, published in the British Journal of Nutrition, ​states: "Matrix Gla protein (MGP) is a vitamin K-dependent inhibitor of soft tissue calcification and elastic fibre degradation. Severe extrahepatic vitamin K​ insufficiency was recently demonstrated in Covid-19 patients, with high inactive MGP levels correlating with elastic fibre degradation rates.

"This suggests that insufficient vitamin K-dependent MGP activation leaves elastic fibres unprotected against SARS-CoV-2 induced proteolysis.

"...The triage theory​ posits that during times of scarcity, micronutrients are reserved for use in processes that form the greatest threat to short-term survival if not properly executed.

"This implies that in case of vitamin K insufficiency, the vitamin is preferentially transported to the liver for the activation of the abovementioned procoagulant factors at the expense of extrahepatic vitamin K-dependent proteins such as MGP."

The review also highlights the link between vitamin D3 and vitamin K2. The authors note that vitamin D administration - part of certain clinical trials protocols for COVID-19 - may induce short-term hypercalcemia, resulting in an accelerated elastic fiber calcification, and degradation.

The report concludes: "the potential role of vitamin K supplementation to prevent the development and progression of severe Covid-19 remains largely unexplored. We would argue that the impact of the current crisis warrants thorough evaluation of the therapeutic potential of vitamin K in Covid-19 pathogenesis for two key reasons.

"Unlike other treatment strategies currently under development for Covid-19 such as dexamethasone, vitamin K does not have any known unfavourable effects in those who do not use vitamin K antagonists.

"Furthermore, it is relatively simple and inexpensive to manufacture contrary to other therapies like remdesivir or convalescent plasma. Taken together this means that effectiveness can be rapidly and cheaply evaluated in clinical trials and easily implemented if proven successful."

Source: The British Journal of Nutrition

Janssen R, Visser MPJ, Dofferhoff ASM, Vermeer C, Janssens W, Walk J.

"Vitamin K metabolism as the potential missing link between lung damage and thromboembolism in Covid-19"​ 

doi: 10.1017/S0007114520003979.

Related news

Related products

show more

Whole-Body Solutions, Backed by Science

Whole-Body Solutions, Backed by Science

Kemin Human Nutrition and Health | 14-Sep-2021 | Technical / White Paper

Kemin Human Nutrition and Health develops products and services with its mission top of mind: healthy people, planet, and business. We strive to sustainably...

Vitamin K2 Amplifies Vitamin D3’s Impact

Vitamin K2 Amplifies Vitamin D3’s Impact

NattoPharma – Gnosis by Lesaffre | 06-Sep-2021 | Data Sheet

Few vitamins work better together than Vitamins K2 and D3. Both fat-soluble vitamins play a central role in how the body utilizes calcium, synergistically...



BIONAP Srl | 02-Sep-2021 | Product Brochure

COGNIGRAPE™ is a standardized solid extract obtained from a Sicilian grape variety. Thanks to the high content of ANTHOCYANINS and PROANTHOCYANIDINS, COGNIGRAPE™...

Related suppliers

Follow us


View more